Loading...

Home
Stock
TEVA

TEVA News & Events

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Forecast Technical Valuation Financials Earnings Should I Buy News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press

Markets

Market Analysis
Crypto
Market Movers
Stock Monitor
All US Stocks

AI Strategies

AI Stock Picker
Swing Trading
Quant AI Alpha Pick
CoinSwing
Daytrading Center
Crypto Radar
Patterns Detection

Resources

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat With Tia
AI Screener
Backtest Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

TEVA News

Teva Pharmaceuticals to Announce Q4 Earnings on January 28

2 days agoseekingalpha

Teva Pharmaceutical Shares Dip After Six-Day Rally Amid Cautious Outlook

15 hours agoseekingalpha

Teva Pharmaceutical Q4 2025 Earnings Exceed Expectations

1 day agoBenzinga

Teva Pharmaceutical Exceeds Q4 2025 Expectations but Projects Lower 2026 Financials

1 day agoseekingalpha

Teva Pharmaceutical Exceeds Expectations, Transitioning to Growth Story

1 day agoseekingalpha

Teva Pharmaceuticals to Host Q4 2025 Earnings Call

1 day agoNASDAQ.COM

Teva Pharmaceutical Q4 Earnings Exceed Expectations

2 days agoseekingalpha

Novo Nordisk Accused of Pay-for-Delay Scheme with Teva to Block Generic Victoza

5 days agoseekingalpha

TEVA Events

Teva Targets FY26 Gross Margin of 54.5%-55.5%

Teva says targeting FY26 gross margin of 54.5%-55.5%

Targets for 2030: Operating Profit Over 30%, FCF Exceeds $3.5B

Targets 2030: Operating profit greater than 30%; Adjusted EBITDA growing; FCF greater than $3.5B; Net leverage less than 2x.

TEVA Monitor News

Teva projects strong revenue growth at J.P. Morgan Conference

Teva Pharmaceutical reaches 52-week high amid S&P upgrade

Teva Pharmaceutical reaches 52-week high amid Eylea biosimilar agreement

Teva reaches 52-week high amid FDA submission for new drug.

Teva hits 52-week high on ETF inflows

Teva Gains Approval for New Biosimilars

TEVA Earnings Analysis

Teva Pharmaceutical Earnings: Q3 2025 Insights- Intellectia AI™

Transformative Year for Teva Pharmaceutical - Intellectia AI™

People Also Watch